Uveal Melanoma - Comparative Study
Conditions: Uveal Melanoma Interventions: Diagnostic Test: Sonography, color fundus photography Sponsors: Medical University of Vienna Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
Conditions: Uveal Melanoma Interventions: Diagnostic Test: Clinical examination and multimodal ocular imaging Sponsors: Medical University of Vienna Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Adjuvant Tebentafusp in High Risk Ocular Melanoma
Conditions: Uveal Melanoma Interventions: Drug: Tebentafusp Sponsors: European Organisation for Research and Treatment of Cancer - EORTC; Northwell Health Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
Conditions: Metastatic Uveal Melanoma Interventions: Drug: ZIV-Aflibercept; Drug: Cemiplimab Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Genzyme, a Sanofi Company; Regeneron Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Psychoeducation for Uveal Melanoma
Conditions: Uveal Melanoma Interventions: Behavioral: Education for Intervention; Behavioral: Best Practice Sponsors: Jonsson Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study
Conditions: Uveal Melanoma Interventions: Other: Questionnaires and interviews Sponsors: Institut Curie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Conditions: Uveal Melanoma Interventions: Drug: Tebentafusp Sponsors: Diwakar Davar; Immunocore Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Conditions: Choroidal Melanoma; Indeterminate Lesions; Uveal Melanoma; Ocular Melanoma Interventions: Drug: Belzupacap Sarotalocan; Device: Suprachoroidal Microinjector; Device: Infrared Laser; Device: Sham Infrared Laser; Device: Sham Microinjector; Drug: Sham Treatment Sponsor: Aura Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Conditions: Choroidal Melanoma; Indeterminate Lesions; Uveal Melanoma; Ocular Melanoma Interventions: Drug: Belzupacap Sarotalocan; Device: Suprachoroidal Microinjector; Device: Infrared Laser; Device: Sham Infrared Laser; Device: Sham Microinjector; Drug: Sham Treatment Sponsor: Aura Biosciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
